Heartseed Inc.
PublicHeartseed Inc. is now publicly traded
The data on this page reflects Heartseed Inc.'s private-market history up to the point it went public, including its funding rounds, valuation, and investors.
Last Round
Series D
May 25, 2023
Total Funding Raised
$84.6M
Company Overview
Heartseed Inc. is a biotechnology company that develops and commercializes iPS cell-derived cardiomyocyte replacement therapy for advanced heart failure.
Sector
Biotech
AI Layer
Non-AI
Keywords
regenerative medicineiPSC therapycardiomyocyte spheroidsheart failure treatmentinduced pluripotent stem cellsiPSCcell therapycardiac regenerationcatheter deliverybiotech startupclinical stage biotechheart tissue repairbiotech licensingregenerative bio
Heartseed Inc. Comparables
Compare Heartseed Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| LizarBio Therapeutics | 70% | |
| AnaCardio | 57% | |
| XellSmart | 52% |
Heartseed Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | May 25, 2023 | ||||
| Series C | Jun 11, 2021 | ||||
| Series B | Nov 22, 2019 | ||||
| Series A | Jul 30, 2018 |
Heartseed Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Angel Bridge | Series A |
| Keio Innovation Initiative | Series D, Series C |
| Medical Incubator Japan | Series D, Series C |
| Nissay Capital | Series B, Series C |
| Astellas Venture Management | Series A, Series B |
| Sumitomo Mitsui Trust Investment | Series D, Series C |
| Sumitomo Mitsui Banking Corporation | Series B, Series C |
Heartseed Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFirmographic Details
HeadquartersTokyo, Tokyo
Employee Range20
Year Founded2015
Last FundingMay 25, 2023
See something wrong or outdated?